Nusko G, Schneider B, Ernst H, Wittekind C, Hahn EG (1997) Melanosis colia harmless pigmentation or a precancerous condition
doi: 10.1007/s40265022-017468 74 LudvikBGiorginoFJdarEFriasJPFernndez LandLBrownKet al
So every provider has, everyone you know, has a patient sign a consent saying you are aware that there's no insurance
This applies universally to melanocortin agonists, growth hormone secretagogues, and incretin mimetics alike
(Yes, the same company that makes slim-down superstar, Zepbound .) And on April 1, 2026, it received approval from the US Food and Drug Administration (FDA) under the brand name Foundayo
What this timeline does not guarantee: automatic approval, a specific prescription, or delivery by a specific date